No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response


  • Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16365
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Ανταγωνιστή α1-αδρενεργικών υποδοχέων
  • Ο ασθενής σας δίνει λεπτομερές ιατρικό ιστορικό
  • Test de identificare a glucozei
  • Επιλογή 1: A και Γ είναι σωστά
  • No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Reminder

FINISH

Time is up